AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Sopharma AD

Earnings Release Apr 20, 2023

2543_rns_2023-04-20_c9027294-81c9-4b6b-aefe-675e948d5c9b.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Current report №19/ 2023 Dated April 20, 2023

NOTIFICATION

"Sopharma" AD (the Company) notifies that for March 2023 the Company recorded an increase in sales of 127% compared to the same month of the previous year, incl. 3% increase in domestic sales and 426% increase in export sales due to the low base in the previous period due to the collapse of sales in the main markets as a result of the conflict between Russia and Ukraine.

For the first three months of 2023, sales increased by a total of 45%, incl. 1% increase of sales for the domestic market and 97% increase in export sales.

Ognian Donev

Talk to a Data Expert

Have a question? We'll get back to you promptly.